| RS387907151 |
DNAAF3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 2, Primary ciliary dyskinesia 2 |
| RS387907152 |
DNAAF3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 2, Primary ciliary dyskinesia |
| RS387907153 |
TINF2
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 3 |
| RS387907154 |
TINF2
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 3 |
| RS387907155 |
KLHL3
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism type 2D, Pseudohypoaldosteronism type 2D |
| RS387907156 |
KLHL3
|
Health Risk |
Pathogenic |
Pseudohypoaldosteronism type 2D, Pseudohypoaldosteronism type 2D |
| RS387907157 |
PTPN11
|
Health Risk |
Pathogenic |
Metachondromatosis, RASopathy |
| RS387907158 |
PTPN11
|
Health Risk |
Pathogenic |
Metachondromatosis, Metachondromatosis |
| RS387907159 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS387907160 |
CRPPA
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS387907161 |
CRPPA
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS387907162 |
CRPPA
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS387907163 |
UVSSA
|
Health Risk |
Pathogenic |
UV-sensitive syndrome 3, UV-sensitive syndrome 3 |
| RS387907164 |
UVSSA
|
Health Risk |
Pathogenic |
UV-sensitive syndrome 3, UV-sensitive syndrome 3 |
| RS387907167 |
H6PD
|
Health Risk |
Pathogenic |
Cortisone reductase deficiency 1, Cortisone reductase deficiency 1 |
| RS387907168 |
HSD11B1
|
Health Risk |
Pathogenic |
Cortisone reductase deficiency 2, Cortisone reductase deficiency 2 |
| RS387907169 |
SOST
|
Health Risk |
Pathogenic |
Craniodiaphyseal dysplasia, autosomal dominant |
| RS387907170 |
ETFDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric acidemia iic, late-onset |
| RS387907172 |
FA2H
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 35, Hereditary spastic paraplegia 35 |
| RS387907173 |
C19orf12
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 4, Neurodegeneration with brain iron accumulation 4 |
| RS387907174 |
LTBP2
|
Health Risk |
Pathogenic |
Microspherophakia, Microspherophakia |
| RS387907175 |
LTBP2
|
Health Risk |
Likely pathogenic |
Microspherophakia, Microspherophakia and/or megalocornea |
| RS387907176 |
THAP1
|
Health Risk |
Pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS387907177 |
THAP1
|
Health Risk |
Pathogenic |
Torsion dystonia 6, Torsion dystonia 6 |
| RS387907178 |
GNAI3
|
Health Risk |
Pathogenic/Likely pathogenic |
Auriculocondylar syndrome 1, Auriculocondylar syndrome 1 |
| RS387907179 |
PLCB4
|
Health Risk |
Pathogenic |
Auriculocondylar syndrome 2, Auriculocondylar syndrome 1 |
| RS387907180 |
ALG11
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG11-congenital disorder of glycosylation, ALG11-related disorder |
| RS387907181 |
ALG11
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG11-congenital disorder of glycosylation, ALG11-related disorder |
| RS387907182 |
ALG11
|
Health Risk |
Pathogenic |
ALG11-congenital disorder of glycosylation, ALG11-congenital disorder of glycosylation |
| RS387907184 |
ALG11
|
Health Risk |
Pathogenic |
ALG11-congenital disorder of glycosylation, ALG11-congenital disorder of glycosylation |
| RS387907185 |
SF3B4
|
Health Risk |
Pathogenic |
Nager syndrome, Nager syndrome |
| RS387907186 |
SF3B4
|
Health Risk |
Pathogenic |
Nager syndrome, Inborn genetic diseases |
| RS387907188 |
GATAD1
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 2B, Dilated cardiomyopathy 2B |
| RS387907190 |
NSUN2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 5 |
| RS387907191 |
NSUN2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 5 |
| RS387907192 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS387907193 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS387907194 |
SMARCA2
|
Health Risk |
Pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS387907196 |
EXOSC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 1B, 7 conditions |
| RS387907197 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Ectodermal dysplasia |
| RS387907198 |
IRX5
|
Health Risk |
Pathogenic |
Craniofacial dysplasia - osteopenia syndrome, Craniofacial dysplasia - osteopenia syndrome |
| RS387907199 |
NDUFS1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 5 |
| RS387907200 |
SPR
|
Health Risk |
Pathogenic |
Dopa-responsive dystonia due to sepiapterin reductase deficiency, Dopa-responsive dystonia due to sepiapterin reductase deficiency |
| RS387907201 |
F2
|
Health Risk |
Pathogenic |
Thrombophilia due to thrombin defect, Congenital prothrombin deficiency |
| RS387907202 |
COG4
|
Health Risk |
Pathogenic |
COG4-congenital disorder of glycosylation, COG4-congenital disorder of glycosylation |
| RS387907203 |
COG4
|
Health Risk |
Pathogenic |
COG4-congenital disorder of glycosylation, COG4-congenital disorder of glycosylation |
| RS387907204 |
FUZ
|
Health Risk |
risk factor |
Neural tube defects, susceptibility to |
| RS387907205 |
KRAS
|
Health Risk |
Likely pathogenic |
Cardiofaciocutaneous syndrome 2, Cardio-facio-cutaneous syndrome |
| RS387907206 |
KRAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiofaciocutaneous syndrome 2, Cardiofaciocutaneous syndrome 2 |
| RS387907207 |
GATA1
|
Health Risk |
Likely pathogenic |
Beta-thalassemia-X-linked thrombocytopenia syndrome, Thrombocytopenia |
| RS387907208 |
ABCC9
|
Health Risk |
Pathogenic |
Hypertrichotic osteochondrodysplasia Cantu type, Dilated cardiomyopathy 1O |
| RS387907209 |
ABCC9
|
Health Risk |
Pathogenic |
Hypertrichotic osteochondrodysplasia Cantu type, Dilated cardiomyopathy 1O |
| RS387907210 |
ABCC9
|
Health Risk |
Pathogenic |
Hypertrichotic osteochondrodysplasia Cantu type, Hypertrichotic osteochondrodysplasia Cantu type |
| RS387907211 |
ABCC9
|
Health Risk |
Likely pathogenic |
Hypertrichotic osteochondrodysplasia Cantu type, Hypertrichotic osteochondrodysplasia Cantu type |
| RS387907212 |
RAD21
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS387907213 |
RAD21
|
Health Risk |
Conflicting classifications of pathogenicity |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS387907214 |
AGPS
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata type 3 |
| RS387907215 |
FAM20A
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1G, Amelogenesis imperfecta type 1G |
| RS387907216 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS387907217 |
KIT
|
Health Risk |
Pathogenic |
Piebaldism, progressive |
| RS387907218 |
TAFAZZIN
|
Health Risk |
Pathogenic |
3-Methylglutaconic aciduria type 2, Primary dilated cardiomyopathy |
| RS387907219 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial digital arthropathy-brachydactyly, Brachyrachia (short spine dysplasia) |
| RS387907220 |
TRPV4
|
Health Risk |
Pathogenic |
Familial digital arthropathy-brachydactyly, Familial digital arthropathy-brachydactyly |
| RS387907221 |
TMEM165
|
Health Risk |
Pathogenic |
TMEM165-congenital disorder of glycosylation, TMEM165-congenital disorder of glycosylation |
| RS387907222 |
TMEM165
|
Health Risk |
Conflicting classifications of pathogenicity |
TMEM165-congenital disorder of glycosylation, TMEM165-congenital disorder of glycosylation |
| RS387907223 |
CDKN1C
|
Health Risk |
Pathogenic |
IMAGe syndrome, IMAGe syndrome |
| RS387907224 |
CDKN1C
|
Health Risk |
Likely pathogenic |
IMAGe syndrome, IMAGe syndrome |
| RS387907225 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Inborn genetic diseases |
| RS387907226 |
CDKN1C
|
Health Risk |
Pathogenic |
IMAGe syndrome, IMAGe syndrome |
| RS387907227 |
ABCC9
|
Health Risk |
Likely pathogenic |
Hypertrichotic osteochondrodysplasia Cantu type, Dilated cardiomyopathy 1O |
| RS387907228 |
ABCC9
|
Health Risk |
Pathogenic |
Hypertrichotic osteochondrodysplasia Cantu type, Dilated cardiomyopathy 1O |
| RS387907229 |
ABCC9
|
Health Risk |
Pathogenic |
Hypertrichotic osteochondrodysplasia Cantu type, Hypertrichotic osteochondrodysplasia Cantu type |
| RS387907230 |
ABCC9
|
Health Risk |
Pathogenic |
Hypertrichotic osteochondrodysplasia Cantu type, Hypertrichotic osteochondrodysplasia Cantu type |
| RS387907231 |
WNT7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Schinzel phocomelia syndrome, Fuhrmann syndrome |
| RS387907232 |
NNT
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency 4, Glucocorticoid deficiency 4 |
| RS387907233 |
NNT
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency 4, Glucocorticoid deficiency 4 |
| RS387907234 |
NNT
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency 4, Glucocorticoid deficiency 4 |
| RS387907235 |
STAR
|
Health Risk |
Pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS387907236 |
SERAC1
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria with deafness, encephalopathy |
| RS387907237 |
MPC1
|
Health Risk |
Pathogenic |
Mitochondrial pyruvate carrier deficiency, Mitochondrial pyruvate carrier deficiency |
| RS387907238 |
MPC1
|
Health Risk |
Pathogenic |
Mitochondrial pyruvate carrier deficiency, Mitochondrial pyruvate carrier deficiency |
| RS387907239 |
HOXB1
|
Health Risk |
Pathogenic |
Facial paresis, hereditary congenital |
| RS387907240 |
CARD14
|
Health Risk |
Pathogenic/Likely pathogenic |
Pityriasis rubra pilaris, Papulosquamous eruptions |
| RS387907242 |
REEP1
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS387907243 |
DPAGT1
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 13, DPAGT1-congenital disorder of glycosylation |
| RS387907244 |
DPAGT1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 13, Congenital myasthenic syndrome 13 |
| RS387907245 |
DPAGT1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 13, Congenital myasthenic syndrome 13 |
| RS387907246 |
KCTD7
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, progressive myoclonic |
| RS387907247 |
TERT
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS387907248 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS387907249 |
TERT
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS387907250 |
TERT
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS387907251 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS387907252 |
VAX1
|
Health Risk |
Pathogenic |
Microphthalmia, syndromic 11 |
| RS387907253 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Marshall-Smith syndrome |
| RS387907254 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS387907255 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Malan overgrowth syndrome |
| RS387907256 |
SLC17A3
|
Health Risk |
association |
Uric acid concentration, serum |
| RS387907257 |
SLC17A3
|
Health Risk |
risk factor |
Uric acid concentration, serum |
| RS387907259 |
KIF1A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 30, Spastic paraplegia 30B |